MaxCyte IPO Presentation Deck

Example: typical single-product revenues from representative license deal 10 July 2021 0 Commercial Phase Low single digit % share of sales, including sale-based payments, annual instrument fees and disposable sales Approval: Year 5+ Multiple 7-figure milestones. Early Clinical: (Phase 1/2) Years 1-3 Mid-6-figure to Low-7-figure milestones 1-3+ Instruments + disposables Mid-late Clinical: (Phase 2/3) Years 3-5+ 7-figure milestone per product Increasing instrument and disposables usage CONFIDENTIAL Cell Therapy Partner Programme Value Schematic Instruments and Processing Assemblies Milestones Sales Based Payments M MaxCyte

View entire presentation